Aimmune Therapeutics, Inc. Separation Agreements

3 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Transition and Separation Agreement, dated November 5, 2017, by and between the Company and Stephen G. Dilly, M.B.B.S., Ph.D
Separation Agreements
Aimmune Therapeutics, Inc.
Biotechnology
CA
2017
TRANSITION AND SEPARATION AGREEMENT
Separation Agreements
Aimmune Therapeutics, Inc.
Biotechnology
CA
2017
TRANSITION AND SEPARATION AGREEMENT
Separation Agreements
Aimmune Therapeutics, Inc.
Biotechnology
CA
2015